Ticker Symbol: ESPR
Esperion Therapeutics Inc.
$8.51 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001434868
Company Profile
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3891 Ranchero Dr Ste 150
Website: www.esperion.com
CEO: Timothy Mayleben
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.96
Change:
$0.00
(
-0.29%)
Days Range: $0.90 - $0.98
Beta: 0.35
52wk. High: $8.86
52wk. Low: $0.70
Ytd. Change -84.72%
50 Day Moving Average: $1.07
200 Day Moving Average: $1.36
Shares Outstanding: 106994269
Valuation
Market Cap: 10.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A